کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
18781 | 42743 | 2006 | 7 صفحه PDF | دانلود رایگان |
Bioconversion of methyl protodioscin (1) by Penicillium melinii was investigated. Seven bioconversion products were isolated and identified. Three of them were glycosidation products and were new compounds. Their structures were identified to be 3-O-[α-l-rhamnopyranosyl-(1 → 2)-{α-l-rhamnopyranosyl-(1 → 4)}-β-d-glucopyranosyl]-26-O-[β-d-glucopyranosyl-(1 → 6)-β-d-glucopyranosyl]-25(R)-furost-5,20(22)-diene-3β,26-triol (2), 3-O-[α-l-rhamnopyranosyl-(1 → 2)-{α-l-rhamnopyranosyl-(1 → 4)}-β-d-glucopyranosyl]-26-O-[β-d-glucopyranosyl-(1 → 6)-β-d-glucopyranosyl]-25(R)-furost-5-ene-3β,26-triol (3), 16β-[4′-methyl-5′-O-(β-d-glucopyranosyl-(1 → 6)-β-d-glucopyranosyl)-pentanoxyl]-pregn-5-en-3β-ol-20-one-O-α-l-rhamnopyranosyl-(1 → 2)-[α-l-rhamnopyranosyl-(1 → 4)]-β-d-glucopyranoside (4), respectively. To the best knowledge we known, this was the first time to find the type of furostanol saponins that had disugar at C-26. The proposed biosynthetic pathways of methyl protodioscin were drawn. Most bioconversion products showed considerable cytotoxic activities against HepG2, NCI-H460, MCF-7 and HeLa cell lines compared to methyl protodioscin.
Journal: Enzyme and Microbial Technology - Volume 38, Issues 3–4, 1 February 2006, Pages 400–406